Cargando…
Height outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Evidence from recent data
Autores principales: | Kamoun, Mahdi, Feki, Mouna Mnif, Abid, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743351/ https://www.ncbi.nlm.nih.gov/pubmed/23961467 http://dx.doi.org/10.4103/2230-8210.113718 |
Ejemplares similares
-
Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
por: Mnif, Mouna Feki, et al.
Publicado: (2013) -
Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Mnif, Mouna Feki, et al.
Publicado: (2012) -
Congenital adrenal hyperplasia: Treatment and outcomes
por: Kamoun, Mahdi, et al.
Publicado: (2013) -
Leydig Cell Tumor Associated with Testicular Adrenal Rest Tumors in a Patient with Congenital Adrenal Hyperplasia due to 11β-Hydroxylase Deficiency
por: Charfi, Nadia, et al.
Publicado: (2012) -
Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Choi, Jin-Ho, et al.
Publicado: (2016)